Gerresheimer increases its glass and plastic production capacities in India


The packaging group has opened a new production plant for plastic containers and closures at its Kosamba manufacturing site.

He also investeda two-digit amount of one million euros”​ in new furnaces at its molded glass plant there, installing a Type I borosilicate melting furnace for the production of white and amber glass using cross-fired oxygen technology and an increased share of electric heating to make melt its barium-free Type I glass formulation.

Thanks to this technology, we will significantly improve the quality of our products and address other market segments,”​ said Stefan Rieder, Global Senior Vice President of Commercial Molded Glass at Gerresheimer.

The company now has four sites in India, dedicated to plastic, molded glass and tubular pharmaceutical primary packaging.

Expanding production capacity in India is part of plans to execute Gerresheimer’s emerging markets growth strategy; he is tackling what he sees as the global megatrend of increasing access to healthcare in these markets and the growing demand for vaccinations.

“India is one of the fastest growing emerging markets and a key market for large global pharmaceutical companies“said Gerresheimer CEO Dietmar Siemssen.

With factories in Europe, North and South America and Asia, the packaging company generates an annual turnover of around 1.4 billion euros. Its range includes pharmaceutical packaging and products such as insulin pens, inhalers, micropumps, pre-fillable syringes, injection vials, ampoules, vials and containers for liquid and solid medications with systems closures and security, as well as cosmetic packaging.

Revenue growth on track

The company announced last month that it delivered double-digit revenue and adjusted EBITDA growth in the first quarter of 2022, raising its full-year revenue guidance. .

Revenue for its plastics and appliances division in the first quarter was 186 million euros ($193.9 million), compared to 155.3 million euros in the same quarter of 2021, it said. -he brings back.

“The demand for plastic packaging and syringes was particularly high, while [the] the contract manufacturing business also evolved positively. Plastic packaging revenues also benefited from price increases as a result of passing on higher resin prices to customers. »


Comments are closed.